Just some of the applications for our platforms


Discovery of modulators of inflammation, innate immunity, and autoimmunity-based disorders.


Developing compounds that target neuroinflammation and neurodegeneration.

Antibiotic Development

Development of biofilm-disrupting  compounds as well as novel classes of antibiotics.

Orphan Diseases

Developing compounds that target rare congenital disorders through targeting novel pathways.


Developing compounds which target pathways that are selectively essential in cancer cells.

Membrane Proteins

Discovery of peptides that modulate the activity of membrane proteins (e.g. GPCRs, solute carrier SLC proteins, and ion channels).